PatchSiren cyber security CVE debrief
CVE-2023-6519 Mia Technology Inc. CVE debrief
CVE-2023-6519 was published on 2024-02-08 and affects Mia-Med versions before 1.0.7. The issue is described as an exposure of data element to the wrong session that can allow sensitive strings within an executable to be read. NVD records a CVSS v3.1 score of 7.5 (High) with network attack vector, no privileges required, and no user interaction, indicating a serious confidentiality-focused exposure for affected deployments.
- Vendor
- Mia Technology Inc.
- Product
- MİA-MED
- CVSS
- HIGH 7.5
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2024-02-08
- Original CVE updated
- 2026-05-20
- Advisory published
- 2024-02-08
- Advisory updated
- 2026-05-20
Who should care
Organizations running Mia-Med before 1.0.7, especially teams responsible for application security, patch management, and handling of sensitive data stored or embedded in the executable. Security responders should also care if the product is deployed in environments where unauthorized reading of embedded strings could expose credentials, endpoints, or other secrets.
Technical summary
NVD lists the vulnerability as an Exposure of Data Element to Wrong Session issue, with a secondary CWE-488 classification from the USOM advisory. The affected CPE is mia-teknoloji/mia-med versions earlier than 1.0.7. The recorded CVSS vector is CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N, which points to a remotely reachable confidentiality issue rather than an integrity or availability impact.
Defensive priority
High. Patch priority should be elevated for any environment that still runs Mia-Med before 1.0.7, because the issue is externally reachable in the CVSS assessment and can expose sensitive information without authentication or user interaction.
Recommended defensive actions
- Upgrade Mia-Med to version 1.0.7 or later.
- Inventory all deployments to confirm no affected versions remain in production, test, or packaged distributions.
- Review whether the executable contains secrets, tokens, endpoints, or other sensitive strings that should be removed or protected.
- Validate session isolation and access-control behavior in any workflows that handle sensitive data elements.
- If exposure is suspected, rotate any credentials or secrets that may have been embedded in affected builds.
- Monitor the vendor and USOM references for any additional remediation guidance or updated advisories.
Evidence notes
The debrief is based only on the supplied NVD record and the linked USOM references. Source data states the issue affects Mia-Med before 1.0.7 and describes it as an exposure of data element to wrong session leading to reading sensitive strings within an executable. NVD metadata also includes CVSS 3.1 vector AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N and a secondary CWE-488 mapping from the USOM advisory. No KEV listing was provided.
Sources and references
Verified primary and authoritative sources
-
CVE-2023-6519 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2023-6519
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2023-6519 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2023-6519
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://siberguvenlik.gov.tr/guvenlik-bildirimleri/detay/tr-24-0087
-
Mitigation or vendor reference
Unverified legacy reference
URL: https://www.usom.gov.tr/bildirim/tr-24-0087
[email protected] - Third Party Advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.